Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Moderate use is typically defined as one drink or less in a day for women and two drinks or less a day for men
K.KhatkarS.et al (2023)
GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
Immediately following stroke, microglia take on an anti-inflammatory and tissue repair-associated phenotype, expressing CD206, Arg1 , Ccl22 , Il10 , and Tgfb1 , with enhanced phagocytic activity for clearing damaged tissue and supporting neuronal recovery and reinnervation [151]
US$ 24.10
US$ 29.06
US$ 22.90
US$ 28.11
US$ 24.29
US$ 27.51
US$ 21.85
US$ 24.81
